EP4415693
FORMULATIONS OF FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
14.10.2022EP published:
18.2.2026EP application number:
22813008.4
EPO information:
European Patent Register
Max expiry date:
13.10.2042Expiry date:
13.10.2026
Title in English:
FORMULATIONS OF FACTOR VIII CHIMERIC PROTEINS AND USES THEREOFLanguage of the patent:
English
Timeline
Today
14.10.2022EP application
18.2.2026EP Publication
13.10.2026Expires
Owner
Name:
Bioverativ Therapeutics Inc.Address:
225 Second Avenue, Waltham MA 02451, US
Inventor
Name:
CARLAGE, TylerAddress:
Waltham, Massachusetts 02451, US
Name:
MAULDIN, RandallAddress:
Waltham, Massachusetts 02451, US
Name:
MCCOY, Timothy R.Address:
Waltham, Massachusetts 02451, US
Name:
TAZI, Loubna MzaalakAddress:
Waltham, Massachusetts 02451, US
Priority
Number:
202163256432 PDate:
15.10.2021Country:
US
Classification
Categories:
A61K 9/19, A61K 47/02, A61K 47/18, A61K 47/26, A61P 7/04, A61K 47/10